P Drasites Kelsey, Shams Ramsha, Zaman Vandana, Matzelle Denise, C Shields Donald, P Garner Dena, J Sole Christopher, Haque Azizul, Banik Narendra L
Department of Neurosurgery, Medical University of South Carolina, 96 Jonathan Lucas St., Charleston, SC 29425, USA.
Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.
Brain Sci. 2020 Dec 2;10(12):933. doi: 10.3390/brainsci10120933.
A spinal cord injury (SCI) may lead to loss of strength, sensation, locomotion and other body functions distal to the lesion site. Individuals with SCI also develop secondary conditions due to the lack of skeletal muscle activity. As SCI case numbers increase, recent studies have attempted to determine the best options to salvage affected musculature before it is lost. These approaches include pharmacotherapeutic options, immunosuppressants, physical activity or a combination thereof. Associated biomarkers are increasingly used to determine if these treatments aid in the protection and reconstruction of affected musculature.
脊髓损伤(SCI)可能导致损伤部位远端的力量、感觉、运动及其他身体功能丧失。由于缺乏骨骼肌活动,脊髓损伤患者还会出现继发性病症。随着脊髓损伤病例数量的增加,最近的研究试图确定在受影响的肌肉组织丧失之前挽救它的最佳方案。这些方法包括药物治疗方案、免疫抑制剂、体育活动或它们的组合。相关生物标志物越来越多地用于确定这些治疗是否有助于保护和重建受影响的肌肉组织。